PDCD1LG2 and esophageal squamous cell carcinoma: Other immunosuppressive co-stimulatory molecules, including PD-L1, PD-L2 and regulatory T cells such as CD4+CD25+T cells, remain under investigation in the context of ESCC and may similarly facilitate the downregulation of anti-tumoral T cell responses.